Who owns the MED365 trademark?

The MED365 trademark is owned by Shield Pharmaceuticals.

What class is the MED365 trademark registered in?

The MED365 trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for MED365?

The USPTO serial number for MED365 is 97598349.

What is the registration number for MED365?

MED365 is registered under USPTO registration number 7306632.

Sealvo

Home Search: MED365MED365 #97598349

Back

Updated Sep 20, 2026·37 searches this week

View on USPTO TSDR Find similar marks

MED

USPTO Trademark Record

REGISTERED

MED365

SN 97598349·Reg 7306632·Filed Sep 20, 2022

Owner Shield Pharmaceuticals

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

MED365 (Serial No. 97598349), Registration No. 7306632, is a registered US trademark filed on Sep 20, 2022 by Shield Pharmaceuticals. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 13, 2030

Conflict Analysis

Full conflict analysis for MED365 (SN 97598349) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

MED365 (Reg. #7306632) is a registered US trademark that has been protecting its owner, Shield Pharmaceuticals, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 20, 2022

SERIAL

97598349

REG#

7306632

REGISTERED

Feb 13, 2024

Filing Information

StatusREGISTERED

Filing DateSep 20, 2022

Serial Number97598349

Registration No.7306632

Registration DateFeb 13, 2024

Status DateFeb 13, 2024

Published for OppositionAug 22, 2023

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 25, 2022

First use in commerce: Oct 25, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 18, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 18, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 18, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Feb 13, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 13, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 12, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 11, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Dec 01, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 30, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Nov 17, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 17, 2023

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 14, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

Sep 21, 2023

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

Sep 13, 2023

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

LETTER OF PROTEST EVIDENCE FORWARDED

Sep 13, 2023

LETTER OF PROTEST EVIDENCE FORWARDED

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 24, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Aug 22, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 22, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 02, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 14, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jun 30, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 26, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 23, 2022

NEW APPLICATION ENTERED

Other Marks by Shield Pharmaceuticals

Additional USPTO filings from the same owner.

CUR

CURERX

99335013

Shield Pharmaceuticals

PENDING

MED365

Run a conflict check

Other Marks by Shield Pharmaceuticals

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company